DK1200445T3 - Thienopyrancarboxamidderivater - Google Patents
ThienopyrancarboxamidderivaterInfo
- Publication number
- DK1200445T3 DK1200445T3 DK00958313T DK00958313T DK1200445T3 DK 1200445 T3 DK1200445 T3 DK 1200445T3 DK 00958313 T DK00958313 T DK 00958313T DK 00958313 T DK00958313 T DK 00958313T DK 1200445 T3 DK1200445 T3 DK 1200445T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- treatment
- urinary tract
- lower urinary
- polyfluoroalkoxy
- Prior art date
Links
- HJYUNRDQEQBDCG-UHFFFAOYSA-N 5H-thieno[3,2-b]pyran Chemical compound C1=CCOC2=C1SC=C2 HJYUNRDQEQBDCG-UHFFFAOYSA-N 0.000 title 1
- 229940053202 antiepileptics carboxamide derivative Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 5
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 abstract 2
- 206010071289 Lower urinary tract symptoms Diseases 0.000 abstract 2
- 208000004403 Prostatic Hyperplasia Diseases 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- -1 polyfluoroalkoxy Chemical group 0.000 abstract 2
- 210000001635 urinary tract Anatomy 0.000 abstract 2
- 208000010228 Erectile Dysfunction Diseases 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 201000001880 Sexual dysfunction Diseases 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 102000030619 alpha-1 Adrenergic Receptor Human genes 0.000 abstract 1
- 108020004102 alpha-1 Adrenergic Receptor Proteins 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 230000001856 erectile effect Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 201000001881 impotence Diseases 0.000 abstract 1
- 230000004410 intraocular pressure Effects 0.000 abstract 1
- 230000001272 neurogenic effect Effects 0.000 abstract 1
- 230000000414 obstructive effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000006684 polyhaloalkyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 231100000872 sexual dysfunction Toxicity 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Superconductors And Manufacturing Methods Therefor (AREA)
- Compositions Of Oxide Ceramics (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1999MI001704A IT1313581B1 (it) | 1999-07-30 | 1999-07-30 | Derivati tienopirancarbossamidici. |
| PCT/EP2000/007306 WO2001009140A1 (en) | 1999-07-30 | 2000-07-28 | Thienopyranecarboxamide derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1200445T3 true DK1200445T3 (da) | 2004-01-12 |
Family
ID=11383457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00958313T DK1200445T3 (da) | 1999-07-30 | 2000-07-28 | Thienopyrancarboxamidderivater |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1200445B1 (da) |
| JP (1) | JP2003506379A (da) |
| KR (1) | KR100705179B1 (da) |
| CN (1) | CN1155602C (da) |
| AT (1) | ATE250068T1 (da) |
| AU (1) | AU759085B2 (da) |
| BR (1) | BR0012871A (da) |
| CA (1) | CA2378302A1 (da) |
| DE (1) | DE60005368T2 (da) |
| DK (1) | DK1200445T3 (da) |
| ES (1) | ES2206296T3 (da) |
| HU (1) | HUP0202106A3 (da) |
| IL (2) | IL147441A0 (da) |
| IT (1) | IT1313581B1 (da) |
| MX (1) | MXPA02000820A (da) |
| NO (1) | NO20020476D0 (da) |
| PL (1) | PL198700B1 (da) |
| PT (1) | PT1200445E (da) |
| RU (1) | RU2225409C2 (da) |
| TW (1) | TWI239958B (da) |
| WO (1) | WO2001009140A1 (da) |
| ZA (1) | ZA200200687B (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY30111A1 (es) * | 2006-02-03 | 2007-04-30 | Recordati Ireland Ltd | Sales de adicion de acido de n-(3-(4-(2-metoxifenil)-1-piperazinil)-propil)-7-oxo-5-trifluormetil-7h-tieno (3,2-b) piran-3-carboxamida |
| US8557807B2 (en) * | 2008-01-24 | 2013-10-15 | Signal Rx Pharmaceuticals, Inc. | Thienopyranones as kinase inhibitors |
| WO2015018823A1 (en) * | 2013-08-08 | 2015-02-12 | Galapagos Nv | Thieno[2,3-c]pyrans as cftr modulators |
| EP3573619A4 (en) * | 2017-01-27 | 2020-10-28 | SignalRX Pharmaceuticals, Inc. | THIENOPYRANONES AND FURANOPYRANONES AS KINASE, BROMODOMAIN AND CHECKPOINT INHIBITORS |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1254469B (it) * | 1992-02-25 | 1995-09-25 | Recordati Chem Pharm | Derivati benzopiranici e benzotiopiranici |
| SG65570A1 (en) * | 1992-02-25 | 1999-06-22 | Recordati Chem Pharm | Heterobicyclic compounds |
| IT1293807B1 (it) * | 1997-08-01 | 1999-03-10 | Recordati Chem Pharm | Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico |
| EP1000045A1 (en) * | 1997-08-01 | 2000-05-17 | RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY | 1,4-disubstituted piperazines |
-
1999
- 1999-07-30 IT IT1999MI001704A patent/IT1313581B1/it active
-
2000
- 2000-07-28 ES ES00958313T patent/ES2206296T3/es not_active Expired - Lifetime
- 2000-07-28 AT AT00958313T patent/ATE250068T1/de not_active IP Right Cessation
- 2000-07-28 WO PCT/EP2000/007306 patent/WO2001009140A1/en not_active Ceased
- 2000-07-28 BR BR0012871-6A patent/BR0012871A/pt not_active Application Discontinuation
- 2000-07-28 CN CNB008109788A patent/CN1155602C/zh not_active Expired - Fee Related
- 2000-07-28 RU RU2002105022/04A patent/RU2225409C2/ru not_active IP Right Cessation
- 2000-07-28 DK DK00958313T patent/DK1200445T3/da active
- 2000-07-28 DE DE60005368T patent/DE60005368T2/de not_active Expired - Fee Related
- 2000-07-28 MX MXPA02000820A patent/MXPA02000820A/es active IP Right Grant
- 2000-07-28 CA CA002378302A patent/CA2378302A1/en not_active Abandoned
- 2000-07-28 JP JP2001514343A patent/JP2003506379A/ja active Pending
- 2000-07-28 KR KR1020027001140A patent/KR100705179B1/ko not_active Expired - Fee Related
- 2000-07-28 PL PL363115A patent/PL198700B1/pl not_active IP Right Cessation
- 2000-07-28 PT PT00958313T patent/PT1200445E/pt unknown
- 2000-07-28 EP EP00958313A patent/EP1200445B1/en not_active Expired - Lifetime
- 2000-07-28 IL IL14744100A patent/IL147441A0/xx active IP Right Grant
- 2000-07-28 TW TW089115124A patent/TWI239958B/zh not_active IP Right Cessation
- 2000-07-28 AU AU69882/00A patent/AU759085B2/en not_active Ceased
- 2000-07-28 HU HU0202106A patent/HUP0202106A3/hu unknown
-
2002
- 2002-01-02 IL IL147441A patent/IL147441A/en not_active IP Right Cessation
- 2002-01-25 ZA ZA200200687A patent/ZA200200687B/en unknown
- 2002-01-29 NO NO20020476A patent/NO20020476D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200200687B (en) | 2002-10-30 |
| PL363115A1 (en) | 2004-11-15 |
| RU2225409C2 (ru) | 2004-03-10 |
| ES2206296T3 (es) | 2004-05-16 |
| CA2378302A1 (en) | 2001-02-08 |
| IL147441A0 (en) | 2002-08-14 |
| KR20020022785A (ko) | 2002-03-27 |
| HUP0202106A3 (en) | 2004-12-28 |
| NO20020476L (no) | 2002-01-29 |
| TWI239958B (en) | 2005-09-21 |
| CN1365363A (zh) | 2002-08-21 |
| EP1200445A1 (en) | 2002-05-02 |
| EP1200445B1 (en) | 2003-09-17 |
| IL147441A (en) | 2007-06-03 |
| JP2003506379A (ja) | 2003-02-18 |
| AU759085B2 (en) | 2003-04-03 |
| NO20020476D0 (no) | 2002-01-29 |
| KR100705179B1 (ko) | 2007-04-06 |
| ATE250068T1 (de) | 2003-10-15 |
| HUP0202106A2 (en) | 2002-10-28 |
| DE60005368D1 (en) | 2003-10-23 |
| ITMI991704A1 (it) | 2001-01-30 |
| MXPA02000820A (es) | 2004-03-19 |
| ITMI991704A0 (it) | 1999-07-30 |
| CN1155602C (zh) | 2004-06-30 |
| WO2001009140A1 (en) | 2001-02-08 |
| AU6988200A (en) | 2001-02-19 |
| DE60005368T2 (de) | 2004-07-01 |
| BR0012871A (pt) | 2002-04-16 |
| IT1313581B1 (it) | 2002-09-09 |
| PL198700B1 (pl) | 2008-07-31 |
| HK1044763A1 (en) | 2002-11-01 |
| PT1200445E (pt) | 2004-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR910006864B1 (ko) | 종양억제제인 방향족 및 헤테로사이클릭 카복스아미드 유도체 | |
| MX9703518A (es) | Dihidropirimidinas y usos de las mismas. | |
| MY122826A (en) | Dipeptide nitrile cathepsin k inhibitors | |
| TR200103095T2 (tr) | Renin engelleyiciler. | |
| ATE401076T1 (de) | Chinolinderivate als glucokinase liganden | |
| WO1998051311A3 (en) | Dihydropyrimidines and uses thereof | |
| BRPI0418245A (pt) | nitróxi-derivados de prostaglandina | |
| WO2001029015A3 (en) | Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists | |
| MY144928A (en) | Benzofuran derivatives | |
| Bi et al. | Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction | |
| ATE357453T1 (de) | Comt-inhibitoren | |
| BR0010693A (pt) | Derivados azaindol para tratamento de depressão | |
| DE60031686D1 (de) | Pyrazinone, diese verbindungen enthaltende zusammenstellungen | |
| ATE389655T1 (de) | Pyrimidinderivate | |
| ATE250068T1 (de) | Thienopyran-carboxamid-derivate | |
| NO20004405L (no) | Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati | |
| KR920702680A (ko) | 인데노인돌 화합물 | |
| ATE297926T1 (de) | Hexahydropyrazino(1'2':1,6)-pyrido(3,4-b)indole 1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen | |
| UY26111A1 (es) | Derivados de ciclobuten-3, 4-diona, su preparación y su aplicación en terapéutica | |
| EP1172360A4 (en) | NEUROTROPHIN POTENTIALIZERS | |
| EP1806136A4 (en) | MEDICAL COMPOSITION PREVENTING THE TRANSITION TO OPERATIVE TREATMENT IN PROSTATE HYPERTROPHY | |
| HK1042090A1 (zh) | N-取代的具有5-羟色胺能活性的酰亚胺衍生物 | |
| AU2003250707A1 (en) | A pharmaceutical formulation and its use in the treatment of inner ear diseases | |
| AU1384701A (en) | Benzopyran derivatives | |
| Patel et al. | Muscarinic receptors of human prostatic stromal cells in vitro |